January 5, 2016
Glenmark confirms reaching agreement with Roche over patent disputes
Glenmark confirms reaching agreement with Roche over patent disputes
Pharmaceuticals, Biotechnology and Life Sciences
Category: Asia
January 5, 2016
Suven’s products gets three patent grants; from Canada, ARIPO, and South Korea
Suven Life Sciences Ltd has announced that the grand of one product patent from Canada, one from ARIPO and one from South Korea corresponding to the New Chemical Entities for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030.
December 31, 2015
Brooks Laboratories’ new manufacturing unit in Vadodra to kick off production in 3 months
Brooks Laboratories’ new manufacturing unit in Vadodra to kick off production in 3 months
December 30, 2015
Dr. Reddy’s re-launches generic version of Nexium
India’s Dr. Reddy’s has re-launched its Esomeprazole Magnesium Delayed-Release Capsules, which is a therapeutic equivalent generic version of Nexium Delayed-Release…
December 29, 2015
Suven gets granted 20th patent from Europe and 8th from Macau patent
Suven Life Sciences Ltd (SUVEN) has got the grant of one product patent from Europe and one product patent from Macau corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2030 and 2029.
December 29, 2015
Nectar Lifesciences appoints Additional Independet Director
Nectar Lifesciences appoints Additional Independet Director
December 22, 2015
Glenmark’s Linezolid, version of Pfizer’s Zyvox, gets nod from FDA
Glenmark Pharmaceuticals Inc., USA has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Linezolid Tablets, 600 mg, the therapeutic equivalent of Zyvox Tablets, 600 mg of Pharmacia and Upjohn Company, a subsidiary of Pfizer, Inc.
December 22, 2015
FDA approves India’s Aurobindo’s generic version of Alcon’s Patanol
Aurobindo Pharma Limited has received final approval from the US Food & Drug Administration (USFDA) to manufacture and market Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1% which makes the product is ready for launch.
December 18, 2015
Managerial changes for Parabolic Drugs Limited
Indian pharmaceutical company Parabolic Drugs Limited has made certain changes to its board of directors. Namely, the company announced on…
December 14, 2015
Alvogen to market Natco’s generic Tamiflu capsules until 2017
Alvogen to market Natco’s generic Tamiflu capsules until 2017.